Schroder Investment Management Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-42,920
| Closed | -$618K | – | 1318 |
|
|
2017
Q1 | $618K | Buy |
+42,920
| New | +$618K | ﹤0.01% | 998 |
|
|
2015
Q2 | – | Sell |
-435,059
| Closed | -$2.9M | – | 1236 |
|
|
2015
Q1 | $2.9M | Hold |
435,059
| – | – | 0.01% | 818 |
|
|
2014
Q4 | $2.77M | Hold |
435,059
| – | – | 0.01% | 857 |
|
|
2014
Q3 | $4.29M | Sell |
435,059
-15,972
| -4% | -$158K | 0.01% | 802 |
|
|
2014
Q2 | $5.08M | Sell |
451,031
-11,983
| -3% | -$135K | 0.01% | 765 |
|
|
2014
Q1 | $5.61M | Sell |
463,014
-17,443
| -4% | -$211K | 0.01% | 747 |
|
|
2013
Q4 | $6.05M | Sell |
480,457
-48,672
| -9% | -$613K | 0.01% | 760 |
|
|
2013
Q3 | $8.82M | Hold |
529,129
| – | – | 0.02% | 657 |
|
|
2013
Q2 | $8.04M | Buy |
+529,129
| New | +$8.04M | 0.02% | 633 |
|